A Phase 2a, Multicenter, Single Arm, Open- Label, Two-stage, Study To Evaluate The Efficacy, Safety, Tolerability And Pharmacokinetics Of Pf-06480605 In Subjects With Moderate To Severe Ulcerative Colitis

Trial Profile

A Phase 2a, Multicenter, Single Arm, Open- Label, Two-stage, Study To Evaluate The Efficacy, Safety, Tolerability And Pharmacokinetics Of Pf-06480605 In Subjects With Moderate To Severe Ulcerative Colitis

Recruiting
Phase of Trial: Phase II

Latest Information Update: 12 Apr 2018

At a glance

  • Drugs PF 6480605 (Primary)
  • Indications Ulcerative colitis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 05 Mar 2018 Planned End Date changed from 1 Sep 2018 to 30 Aug 2018.
    • 05 Mar 2018 Planned primary completion date changed from 1 Jun 2018 to 14 Jun 2018.
    • 20 Feb 2018 Status changed from active, no longer recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top